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Hoiamide A, a novel bioactive cyclic depsipeptide,
was isolated from an environmental assemblage
of the marine cyanobacteria Lyngbya majuscula
and Phormidium gracile collected in Papua New
Guinea. This stereochemically complex metabolite
possesses a highly unusual structure, which likely
derives from a mixed peptide-polyketide biogenetic
origin, and includes a peptidic section featuring an
acetate extended and S-adenosyl methionine modi-
fied isoleucine moiety, a triheterocyclic fragment
bearing two a-methylated thiazolines and one thia-
zole, and a highly oxygenated and methylated C15-
polyketide substructure. Pure hoiamide A potently
inhibited [3H]batrachotoxin binding to voltage-gated
sodium channels (IC50 = 92.8 nM), activated sodium
influx (EC50 = 2.31 mM) in mouse neocortical neurons,
and exhibited modest cytotoxicity to cancer cells.
Further investigation revealed that hoiamide A is a
partial agonist of site 2 on the voltage-gated sodium
channel.
INTRODUCTION
For more than 30 years, cyanobacteria, or blue-green algae,
have shown an exceptional capacity to produce structurally
diverse and highly bioactive secondary metabolites (Tidgewell
et al., 2009). Although chemical investigations of freshwater
species occurred as early as the 1930s (Fitch et al., 1934), it
was the late Richard E. Moore who pioneered the chemical
and biosynthetic exploration of marine cyanobacteria, beginning
in 1977 with his report onmajusculamides A and B (Marner et al.,
1977). The continuing interest in the natural products of marine
cyanobacteria is reflected in the rich literature, which has
reported more than 678 compounds from these organisms,
many of which possess biomedically relevant properties (Tidge-
well et al., 2009). Indeed, numerous reviews of the chemistry
(Tan, 2007; Van Wagoner et al., 2007; Sivonen and Borner,
2008), biological properties (Grindberg et al., 2008; Ersmark
et al., 2008; Paul et al., 2007; Sielaff et al., 2006), and biosyn-Chemistry & Biology 16, 8thetic pathways (Ramaswamy et al., 2006; Moore, 2005) of
marine cyanobacteria have appeared in recent years.
Among the reported bioactivities of marine cyanobacterial
metabolites, a growing number of these appear to target the
mammalian voltage-gated sodium channels (VGSCs), either as
blockers (Wu et al., 2000; Edwards et al., 2004) or activators
(Li et al., 2001). VGSCs are responsible for the rapid influx of
sodium that underlies the rising phase of the action potential in
electrically excitable cells, including neurons (Catterall et al.,
2007). They are composed of voltage-sensing and pore-forming
elements in a single protein complex of one principal a subunit
(220–260 kDa) and one or two auxiliary b subunits (33–36 kDa)
(Catterall et al., 2007; Denac et al., 2000; Taylor and Meldrum,
1995). Chemical substances with activity at the VGSCs may
possess therapeutic value in the treatment of epilepsy, neuro-
pathic pain, brain damage from ischemia and certain types
of stroke, as well as heart failure (Denac et al., 2000). VGSCs
serve as the molecular targets for toxins that act at six or more
distinct receptor sites on the channel protein (Catterall et al.,
2007). They include tetrodotoxin (TTX), saxitoxin, and m-cono-
toxin (neurotoxin site 1); batrachotoxin, veratridine, aconitine,
and grayanotoxin (neurotoxin site 2); a-scorpion toxins and sea
anemone toxins (neurotoxin site 3); b-scorpion toxins (neuro-
toxin site 4); brevetoxins and ciguatoxin (neurotoxin site 5);
d-conotoxin (neurotoxin site 6); DDT and pyrethoids (neurotoxin
site 7); and antillatoxin (undefined receptor site) (Catterall et al.,
2007; Li et al., 2001; Denac et al., 2000; Taylor and Meldrum,
1995). Currently, therapeutic uses of drugs that modulate
sodium channel function include local anesthetics, antiarryth-
mics, anticonvulsants, and neuroprotective agents (Taylor and
Meldrum, 1995). Because of their high affinity and specificity,
natural product sodium channel ligands have served as impor-
tant tools to explore the structure and function of VGSCs (Catter-
all et al., 2007).
As part of our ongoing assay-based screening program for
new neuroactive compounds from cyanobacteria, we found
that the extract of a Papua New Guinea consortium of two
cyanobacteria, Lyngbya majuscula and Phormidium gracile,
exhibited potent inhibition of calcium oscillations and activation
of sodium influx in mouse cerebrocortical neurons. Additionally,
modest cytotoxicity against human lung adenocarcinoma (H460)
and mouse neuroblastoma (Neuro2a) cell lines was recorded for
this extract. A combination of bioassay and 1H nuclear magnetic93–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 893
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Structure and Pharmacology of Hoiamide ATable 1. NMR Data of Hoiamide A (1) in DMSO-d6
Unit Carbon dC
a dH, multiplicity (Hz)
b COSY HMBC (1H to 13C) NOESY
Thr 1 170.2
2 58.0 4.55, dd (7.7, 2.8) 2NH, 3 1, 3 4
NH 7.86, d (8.0) 2 2, 3, 5 4, 6, 7
3 66.0 4.28, m 2, 4
4 20.2 1.15, d (6.6) 3 2, 3 2, 2NH
Hiva 5 169.4
6 75.8 4.91, d (3.4) 7 5, 7, 8, 9, 10 2NH, 8
7 30.0 2.18, m 6, 8, 9 8 2NH
8 18.9 0.90, d (6.9) 7 6, 7, 9 6
9 16.0 0.76, d (6.9) 7 6, 7, 8
Ahdhe 10 174.2
11 44.3 2.30, dq (9.0, 7.2) 12, 18 10, 12, 18 13NH
12 71.1 3.78, d (9.6) 11 10, 11, 18 17, 18
13 52.6 3.53, dd (11.4, 10.2) 13NH, 14 14, 17, 19 15a, 17, 18
NH 6.82, d (9.8) 13 12, 13, 19 11, 14, 22
14 35.8 1.55, m 13, 15b, 17 13NH
15 25.1 a1.04, ddq (13.8, 7.8, 7.2) 15b, 16 13, 16, 17 13
b1.42, m 14, 15a, 16 14
16 11.1 0.838, t (6.3) 15a, 15b 15
17 15.6 0.85, d (6.0) 14 13, 14, 15 12, 13
18 13.8 0.95, d (6.8) 11 10, 11, 12 12, 13
MoCys1 19 173.1
20 84.6
21 41.0 a3.19, d (11.4) 21b 19, 20, 22, 23 22
b3.81, d (11.4) 21a 19, 20, 22, 23 22
22 25.4 1.54, s 19, 20, 21 21a, 21b, 13NH
MoCys2 23 175.8
24 83.3
25 42.6 a3.46, d (11.2) 25b 23, 24, 26, 27 26
b3.51, d (11.0) 25a 23, 24, 26
26 24.1 1.63, s 23, 24, 25 25a
MoCys3 27 162.1
28 147.4
29 122.4 8.01, s 27, 28, 30
Dmetua 30 168.3
31 33.1 a2.92, dd (15.8, 2.0) 31b, 32 30 34, 43
b2.99, dd (15.8, 9.2) 31a, 32 30, 32 43
32 79.5 3.80, m 31a, 31b, 33 30, 43, 44 43
33 35.7 2.34, m 32, 34, 43 32, 34 35, 44
34 75.2 5.18, d (9.8) 33, 35 1, 32, 33, 35, 36, 42 31a, 36, 43
35 38.5 1.70, dq (7.8, 7.2) 34, 36, 42 33, 36, 42 33, 41, 43
36 72.1 3.18, dd (10.2, 1.4) 35, 37 34, 38, 41 34, 38b, 42
37 33.6 1.48, m 36, 38a, 38b, 41 38, 39 42
38 36.6 a1.15, m 37, 39 36, 37, 39, 40, 41 36
b1.26, m 37 37, 39, 40, 41
39 19.9 1.25, m 38a, 40 38
40 14.3 0.835, t (6.8) 39 39
41 11.9 0.72, d (6.6) 37 36, 37, 38 35
42 10.0 0.82, d (6.8) 35 35, 36 36, 37894 Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved
Chemistry & Biology
Structure and Pharmacology of Hoiamide ATable 1. Continued
Unit Carbon dC
a dH, multiplicity (Hz)
b COSY HMBC (1H to 13C) NOESY
43 10.8 0.838, d (6.3) 33 32, 33, 34 31a, 31b, 32, 34, 35
44 56.7 3.23, s 32 33
aRecorded at 125 MHz.
bRecorded at 500 MHz.resonance (NMR)–guided fractionation led to the discovery of
a highly unusual cyclic peptide, named hoiamide A (1), as the
major bioactive component of the extract. Here, we describe
the isolation and structure elucidation of this novel natural
product, including complete stereochemistry and a detailed bio-
logical evaluation of its neuroactive properties and site of action
at the mammalian VGSC.
RESULTS AND DISCUSSION
Hoiamide A: Isolation and Planar Structure Elucidation
A dark purple composite collection of two intertwined cyanobac-
teria, Lyngbya majuscula and Phormidium gracile, was collected
by SCUBA in Hoia Bay, Papua New Guinea. The cyanobacterial
collection was extracted repeatedly with CH2Cl2/MeOH (2:1) and
was fractioned by silica gel vacuum column chromatography to
produce nine fractions (A–I). Fraction F was found to be highly
active in suppressing calcium oscillations in mouse neocortical
neurons and was thus subjected to a 1H NMR-guided fraction-
ation composed of repetitive silica gel flash column chromatog-
raphy followed by reversed-phased high-performance liquid
chromatography (HPLC) to yield the new natural product hoia-
mide A (1) {[a]23D +5 (c 5.5, CHCl3)}. Pure hoiamide A showed
exceptional potency in suppressing calcium oscillations in this
neuron preparation (IC50 = 47.5 nM).
HRESIMS of 1 yielded an [M+H]+ peak at m/z 926.4446, with
a complex isotopic pattern composed of m/z 926/927/928/
929/930 (100:58:28:10:3 ratio), suggesting the presence of at
least three sulfur atoms. Combining this information with NMR
spectroscopic data (Table 1), it was possible to derive the
molecular formula C44H70N5O10S3 (calcd for C44H71N5O10S3,
926.4441), exhibiting 12 degrees of unsaturation. Acetylation of
1 under standard conditions afforded a triacetate derivative (2)
with an [M+H]+ ion at m/z 1052.4743 (calcd for C50H78N5O13S3,
1052.4758), suggesting the presence of three OH groups. A 1H
NMR spectrum of 1 in dimethyl sulfoxide (DMSO)–d6 (Table 1)
displayed resonances characteristic of a peptide containing
numerous aliphatic and oxygenated residues, including one
aromatic singlet at d8.01; two exchangeable NH peaks at
d7.86 (d, J = 8.0 Hz) and d6.82 (d, J = 9.8 Hz); eight methines
adjacent to O/N at d5.18 (d, J = 9.8 Hz), d4.91 (d, J = 3.4 Hz),
d4.55 (dd, J = 7.7, 2.8 Hz), d4.28 (m), d3.80 (m), d3.78 (d, J =
9.6 Hz), d3.53 (dd, J = 11.4, 10.2 Hz), and d3.18 (dd, J = 10.2,
1.4 Hz); one methoxy group at d3.23; and two methyl singlets
at d1.63 and d1.54, respectively. The readily interpretable 1H
NMR data were completed by eight methyl doublets at d1.15
(d, J = 6.6 Hz), d0.95 (d, J = 6.8 Hz), d0.90 (d, J = 6.9 Hz), d0.85
(d, J = 6.0 Hz), d0.838 (d, J = 6.3 Hz), d0.82 (d, J = 6.8 Hz),
d0.76 (d, J = 6.9 Hz), and d0.72 (d, J = 6.6 Hz), as well as two
methyl triplets at d0.838 (t, J = 6.3 Hz) and d0.835 (t, J =Chemistry & Biology 16, 86.8 Hz). An extensive analysis by two-dimensional (2D) NMR,
including heteronuclear single-quantum correlation (HSQC),
heteronuclear multiple bond correlation (HMBC), correlation
spectroscopy (COSY), total correlation spectroscopy (TOCSY),
and nuclear overhauser effect spectroscopy (NOESY), revealed
three interconnected partial structures, which constituted the
entirety of hoiamide A (1) (Figure 1).
Thepeptidic fragment I (Figure 1)was found tobe composedof
threonine (C1-C4), 2-hydroxyisovaleric acid (Hiva, C5-C9), and
a new C3-extended isoleucine residue (4-amino-3-hydroxy-
2,5-dimethylheptanoic acid, Ahdhe, C10-C18). COSY correla-
tions between a proton at d3.53 (Ahdhe-H13), an exchangeable
proton at d6.82 (Ahdhe-C13-NH), and a methine proton at d1.55
(Ahdhe-H14) suggested an additional aliphatic amino acid
subunit. The high field methine proton was further coupled to
protons defining a sec-butyl side chain, according to HMBC
and TOCSY data, thus suggesting the amino acid isoleucine.
However, the H13 ‘‘alpha’’ proton showed additional coupling
to an oxygenated methine at d3.78 (d, J = 9.6 Hz, Ahdhe-H12)
with an associated carbon at d71.1 (Ahdhe-C12). This latter
proton signal was coupled to an upfield methine at d2.30 (dq,
J = 9.0, 7.2 Hz, Ahdhe-H11), which, in turn, showed COSY corre-
lations to a methyl doublet at d0.95 (J = 6.8 Hz, Ahdhe-H18).
Finally, the H11 methine was shown by HMBC to be adjacent
to the carbonyl at d174.2 (Ahdhe-C10); hence, this residue was
defined as a three-carbon extended isoleucine residue. Long-
distance HMBC correlations between the exchangeable proton
at d7.86 (Thr-C2-NH) and carbon resonances at d58.0 (Thr-C2),
d66.0 (Thr-C3), and d169.4 (Hiva-C5), as well as between the
a-proton at d4.91 (Hiva-H6) and carbons at d169.4 (Hiva-C5),
d30.0 (Hiva-C7), and d174.2 (Ahdhe-C10), firmly established the
connectivity among these three residues. Similar modifications
of Ile to produce Ahdhe-like residues have been observed in
several other marine natural products, such as didemnins A–E
(Rinehart et al., 1988) and various dolastatins (Pettit et al., 1987;
Luesch et al., 2001a). In the case of hoiamide A (1), the ketide-
extended isoleucine is methylated at the a-carbon, likely from
S-adenosyl methionine (SAM). This finding contrasts with the
pattern of methylation seen in dolastatin 10 (see Supplemental
Data available online), wherein methylation occurs on the result-
ing secondary alcohol at the b position (e.g., the alcohol deriving
from reduction of the former Ile carbonyl group). Notably,
a consequence of this alternate site of methylation in hoiamide
A is the creation of an additional stereocenter in the molecule.
A second substructure in 1 (Figure 1) was initiated by HMBC
correlations between a methyl singlet at d1.54 (MoCys1-H22)
and quaternary carbons at d173.1 (MoCys1-C19) and d84.6
(MoCys1-C20), as well as a methylene at d41.0 (MoCys1-C21),
and suggested an a-methyl substituted cysteine-type residue
(MoCys: modified cysteine). The diastereotopic methylene93–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 895
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Structure and Pharmacology of Hoiamide Aprotons at d3.81 (MoCys1-H21b) and d3.19 (MoCys1-H21a), in
combination with a key HMBC correlation between both H21
protons and the C23 deshielded carbon signal at d175.8, defined
this as a cyclized thiazoline. Additional HMBC correlations
between the various protons of this system and all neighboring
carbons two or three bonds away helped confirm these assign-
ments (Table 1). The deshielded signal at d175.8 (MoCys2-C23)
showed HMBC correlations to a second uniquely deshielded
singlet methyl group at d1.63 (MoCys2-C26), and thus provided
linkage to an additional residue. A series of 1H and 13C NMR
signals highly comparable to those in MoCys1 were identified
from HMBC data, establishing this second methyl substituted
thiazoline residue (Table 1). MoCys2 was linked to a thiazole
ring via tandem HMBC correlations between a deshielded
quaternary carbon at d162.1 (MoCys3-C27) and both the C25
protons and a deshielded singlet proton (d8.01, MoCys3-H29).
The two other carbon atoms of this latter residue were also iden-
tified by HMBC couplings from the lone thiazole proton and from
Figure 1. Structure of Hoiamide A (1)
Structure of hoiamide A (1) (A) and partial struc-
tures derived from NMR data (B) and their
assembly by key HMBC correlations.
their distinctive 13CNMR shifts. A compa-
rable arrangement of two methylated
thiazolines followed by a thiazole hetero-
cycle was first reported in the tantazole
(Carmeli et al., 1990, 1993) and miraba-
zole (Carmeli et al., 1991) series of highly
bioactive cyanobacterial metabolites,
and the reported chemical shift data
closely match that reported here for hoia-
mide A (1) at similar positions. Because
substructure II was composed of two
thiazolines and one thiazole, all three of
which are cysteine-derived, the sulfur
component of the molecular formula
was fully satisfied. Finally, HMBC correla-
tions between the protons at d6.82
(Ahdhe-C13-NH) and d3.53 (Ahdhe-H13)
with the carbonyl resonance at d173.1
(MoCys1-C19) provided linkage between
fragments I and II in hoiamide A.
The final fragment (III) of hoiamide A (1)
was determined to be a C15-polyketide
(C30-C44) possessing high levels of
methylation and oxygenation (Figure 1).
The thiazole carbon resonance in frag-
ment II at d168.3 (Dmetua-C30) showed
HMBC correlations to diastereotopic
methylene protons at d2.99 (dd, J =
15.8, 9.2 Hz, Dmetua-H31b) and d2.92
(dd, J = 15.8, 2.0 Hz, Dmetua-H31a) (dC
33.1). These methylene protons showed
COSY correlations to a deshielded
methine proton at d3.80 (Dmetua-H32),
which, in turn, was connected by HMBC
to the methyl group of a methoxy resonance as well as to
another deshielded methine (d5.18, Dmetua-H34). By 1H and
13C NMR chemical shift arguments, this signal was proposed to
be attached to an ester, a hypothesis later verified by HMBC
(see below). However, because this ester methine signal was
strongly coupled to two different high field methine resonances
according toCOSYdata, it was placed beta to the d3.80methine.
The d2.34methine (Dmetua-H33) predicted to intervene between
these two deshielded methines was also proton coupled to
a doublet methyl, and HMBC between the d3.80 signal and the
carbonatomof thismethyl group (d10.8, Dmetua-C43) confirmed
these atom relationships. The methine to the other side of the
d5.18 signal was part of a connected spin system involving
sequential methylmethine, oxymethine, methylmethine, and
methylene groups (Table 1). By chemical shift arguments
(d3.18, Dmetua-H36) and consideration of themolecular formula,
the oxymethine at C36 was deduced to be a free secondary
hydroxyl group. The latter methylene of this spin system was896 Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved
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partial fragment III as a 5,7-dihydroxy-3-methoxy-4,6,8-trime-
thylundecanoyl–derived residue (Dmetua). With fragments I–III
accounting for all atoms of the molecular formula of 1 but only
11of 12degreesof unsaturation, itwas concluded that the overall
molecule formed amacrocycle. The deshieldedmethine at d5.18
(Dmetua-H34)exhibitednumerousHMBCcross-peaks (Figure1),
including a highly prominent three-bond correlation with an ester
carbon at d170.2 (Thr-C1), and thus established the macrocyclic
planar structure of hoiamide A (1).
Hoiamide A: Relative and Absolute Stereochemistry
Next, we turned our attention to the absolute stereochemistry of
hoiamide A (1). With 15 stereocenters, our initial strategy was to
attempt crystallization to perform an X-ray analysis. Unfortu-
nately, numerous efforts aimed at forming crystals from the
natural product 1, its triacetate (2), or the freshly prepared
mono p-bromobenzoic ester derivative (3) failed to produce X-
ray quality crystals. Thus, hoiamide A (1) was hydrolyzed with 6
N HCl (110C, 22 hr), and the hydrolyzate was subjected to chiral
HPLC, revealing the presence of (S)-Hiva in comparison with
commercial standards. The same chromatographic technique
was applied to another sample of 1, which was first subjected
to ozonolysis and oxidative workup prior to hydrolysis, and led
to the detection of 2-methylcysteic acid (MCya). Comparison
of retention times with freshly synthesized MCya standards
(Pattenden et al., 1993; Calmes et al., 1997) confirmed the
occurrence of only (S)-MCya. Marfey’s analysis (Marfey, 1984)
was performed using aliquots of the acid hydrolyzate as well
as amino acid standards, employing N-(3-fluoro-4,6-dinitro-
phenyl)-L-alaninamide (L-FDAA) as the derivatizing agent, and
revealed the presence of (2S,3R)-Thr in hoiamide A (1).
The relative stereochemistry of the C10-C18 (C3-extended Ile)
and C30-C44 (Dmetua) sections was elucidated via J-based
configuration analysis (Figure 2) (Matsumori et al., 1999). This
procedure makes use of 3JH-H and
2-3JC-H values combined
with nuclear Overhauser effect (NOE) and rotational nuclear
Overhauser effect (ROE) data to determine the conformation of
adjacent stereocenters and has been successfully applied to
define the relative stereochemistry of substituted polyketides
in other cyanobacterial metabolites, such as phormidolide (Wil-
liamson et al., 2002), apratoxin A (Luesch et al., 2001b), and
largamide H (Plaza and Bewley, 2006). Homonuclear coupling
constants were obtained from 1H-NMR, E.COSY (Griesinger
et al., 1987), and one-dimensional TOCSY (Uhrin and Barlow,
1997) spectra, whereas heteronuclear coupling values were
accurately measured from heteronuclear long-range coupling
(HETLOC) (Uhrin et al., 1998) and heteronuclear single-quantum
multiple bond correlation (HSQMBC) (Williamson et al., 2000)
experiments (Marquez et al., 2001). Starting with the C10-C18
section, the relative stereochemistry along C11-C12 could not
be determined using J values alone because these did not distin-
guish between the two possible rotamers (threo A3, erythro B3)
with H11/H12 in an anti relationship (3JH11-H12 = 9.0 Hz). Fortu-
nately, NOESY data revealed the spatial proximity of H18 and
H12, H18 and H13, as well as H11 and C13-NH, in agreement
only with the erythro rotamerB3. Small homonuclear and hetero-
nuclear J values were observed between C12 and C13, a result
consistent only with the threo rotamer A1. The H13-H14 protonsChemistry & Biology 16, 8were also in an anti configuration (3JH13-H14 = 9.6 Hz); thus, NOE
correlations between H13/H17, H12/H17, and H14/C13-NH
confidently assigned it as rotamer B3.
The C30-C44 section (Dmetua) exhibited anti configurations
between adjacent methines C32-C33 (3JH32-H33 = 7.9 Hz), C33-
C34 (3JH33-H34 = 9.6 Hz), and C35-C36 (
3JH35-H36 = 10.2 Hz),
which upon analysis of key NOE correlations (H31/H43, H43/
H35, and H42/H37, respectively), were assigned as erythro
rotamers B3. The remaining 1,2-methine systems C34-C35
(3JH34-H35 = 0 Hz) and C36-C37 (3JH36-H37 = 0 Hz) were
deduced to possess gauche conformations between their
protons and were found to be threo rotamers A1 in accordance
with their heteronuclear J values. This proposed configuration
was in agreement with all of the NOEs observed within each of
the substructures.
Connection of the relative stereochemistry of the Ahdhe (C10-
C18) portion with the MoCys1 residue was made possible
through NOE interactions between the methine protons at
d2.30 (Ahdhe-H11) and d1.55 (Ahdhe-H14) with the NH proton
at d6.82 (Ahdhe-C13-NH), which, in turn, was correlated with
the methyl singlet at d1.54 (MoCys1-H22) (Figure 2). Moreover,
because we had established the absolute configuration of the
MoCys1 residue, these observed NOEs allowed assignment of
the absolute stereochemistry of Ahdhe as 11R, 12S, 13S, and
14S. Molecular modeling studies of compound 1 (Supplemental
Data) confirmed that this NOE interaction was only possible with
the S configuration at Ahdhe-C13. Thus, as with dolastatin 10,
the natural configuration of Ile [e.g., L-(2S,3S)-Ile] appears to
have been one of the precursors to this portion of hoiamide A (1).
Our initial plan for determining the absolute stereochemistry
of the Dmetua substructure (C30-C44) was to form the C36
Mosher’s ester derivative of compound 1. However, this position
in hoiamide A (1) proved to be quite resistant to acylation using
Mosher’s acid chloride. Instead, loss of H2O from the Thr residue
yielded the C2-C3 olefinic derivative 4 (Figure 3). Likely, steric
effects disfavor reaction with the bulky a-methoxy-a-trifluoro-
methylphenylacetic acid (MTPA) chloride. As an alternative
approach, 26 mg of the acid hydrolyzate of 1 was dissolved in
MeOH/HCl and stirred at room temperature over an extended
period so as to produce methyl esters of the various units
composing hoiamide A (1). Upon solvent removal under vacuum,
the residue was partitioned between EtOAc and H2O, and
both layers were subjected to extensive reversed-phase HPLC,
1H-NMR, and liquid chromatographymass spectrometry (LCMS)
analyses, in a search for theC10-C18andC30-C44sections.One
such fragment, 5 {[a]23D +18 (c 0.015, MeCN)} (Figure 3), was
a major component of the EtOAc fraction and displayed an M+
at m/z 355.1806 consistent with the molecular formula
C18H29NO4S (calcd 355.1812, 5 degrees of unsaturation).
The 1H NMR spectrum of 5 (Table 2) showed diagnostic reso-
nances for portions of the Dmetua substructure of 1: a thiazole
aromatic singlet at d8.09; a methoxy singlet at d3.95; three
oxygenated methines at d3.70 (d, J = 9.6 Hz), d3.43 (dd, J =
10.2, 4.8 Hz), and d2.88 (dd, J = 10.2, 1.8 Hz); three methyl
doublets at d0.96 (J = 6.6 Hz), d0.88 (J = 6.0 Hz), and d0.87
(J = 7.2 Hz); and one methyl triplet at d0.79 (J = 7.2 Hz). Surpris-
ingly, the singlet at d3.95 (H18) exhibited HMBC correlations with
quaternary carbon resonances at d161.6 (C1) and d145.6.6 (C2),
indicating that this was a methyl ester at the C terminus of the93–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 897
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Structure and Pharmacology of Hoiamide AFigure 2. Homonuclear and Heteronuclear Coupling Constant Values Used to Assign the Relative Configuration of Ahdhe (C10-C18) and
Dmetua (C30-C44)
The magnitude of the coupling constants, (S) for small and (L) for large, allowed identification of gauche and anti orientations between the indicated atoms. For
1,2-methine systems in which the threo rotamer A3 can not be distinguished from the erythro rotamer B3, NOE data (4) provided an unambiguous assignment.898 Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved
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(dd, J = 14.4, 10.2 Hz, H5b) and d3.12 (dd, J = 14.4, 1.8 Hz, H5a)
showed HMBC cross-peaks with carbons at d169.2 (C4) in the
thiazole ring, a methyl-bearing methine at d39.2 (C7), and the
oxygenatedmethine at d77.5 (C6), which, in turn, was connected
to another methine at d83.2 (C10) through an ether linkage. This
latter linkage was established on the basis of reciprocal HMBC
correlations between their attached protons (H6/C10 and H10/
C6). Moreover, this ether bridge formed a new six-membered
heterocycle in derivative 5, thereby satisfying the required 5
degrees of unsaturation. Additional 2D NMR data placed
a 2-pentyl side chain on the carbon at d83.2 (C10) and the final
oxygenated methine at d3.43 (H8) flanked by methyl-bearing
methines at d1.95 (H7) and d1.68 (H9) to either side; each of
the latter was connected to the bridged system described
above. This analysis allowed assignment of the
planar structure of derivative 5 (Figure 3), which likely results
from the Dmetua residue via displacement of the methoxy
group at C32 by the C36 hydroxy group with inversion of config-
uration (the absence of an epimer at C6 in 5 supports an SN2
mechanism). (Neighboring group participation [anchimeric
assistance] by the thiazole-ring sulfur lone pair might stabilize
aRelative configuration and rotamer designation according to Matsumori et al. (1999).
bWeak couplings with 3JH,H < 0.5 Hz were considered as 0 Hz.
cNo correlation observed in HSQMBC as expected for a coupling of 0 Hz.
Figure 3. Chemical Degradation Efforts Used in
Determining the Absolute Stereochemistry of
Hoiamide A
Reagents and conditions: (a) 6M HCl, 110C, 22 hr; (b)
MeOH, HCl(cat), 25
C, 3 weeks; (c) solvent partitioning
H2O/EtOAc; and (d) MTPA, pyridine, DMAP, 25
C, 18 hr.
the protonated and thus positively charged
oxygen atom of the leaving group [MeOH] via
a five-membered ring intermediate, thus
favoring an SN2 nucleophilic substitution.)
Further NMR analysis of compound (5)
provided insightful information on the relative
configuration of Dmetua, which confirmed the
assignments made by J-based configurational
analysis. The highly shielded methyl doublet at
d0.96 (H17) was situated in an axial position,
together with protons at d3.70 (H6), d3.43 (H8),
d1.68 (H9), and d2.88 (H10), based on coupling
constant information. Such an arrangement was
consistent with NOESY data (Figure 3), which
additionally defined the stereocenter at C11
outside the tetrahydropyran ring. The absolute
stereochemistry at C8 was determined as S by
the modified Mosher method (Ohtani et al.,
1991), andwith the relative configuration of 1 es-
tablished via J-based analysis and of 5 by 1H-1H
coupling constants and NOE data, the absolute
stereochemistry of the Dmetua fragment could
be assigned as 32S, 33S, 34R, 35S, 36S, and
37R. This completed the assignment of struc-
ture and stereochemistry of hoiamide A (1).
Hoiamide A (1) represents a particularly interesting example of
a natural product deriving from a mixture of the polyketide syn-
thase (PKS) and nonribosomal peptide synthetase (NRPS) path-
ways. The initial polyketide section, the Dmetua fragment, is
unique to 1 and shows a typical remnant oxidation pattern at
several sites, as well as methylation at the C-2 positions of pre-
dicted acetate units, which entirely derive from SAMmethylation
events in cyanobacteria. Excluding the branching carbons of the
Dmetua moiety, the carbon chain is eleven carbons long and
suggests either a propionate starter unit, the SAMmethylation of
an acetate starter, or a truncation of a hexaketide. Of these alter-
natives, we favor the SAM methylation possibility because (a)
propionate is unknown as a starter unit in cyanobacterial polyke-
tides (Grindberg et al., 2008), and (b) the remaining oxidations
and methylations are positionally inconsistent with a terminal
decarboxylation. Next, an intriguing tetrapeptide is created, with
the three cysteine residues subject to heterocyclization reactions
followed by dehydration. The first of these is further modified by
oxidation to the thiazole ring,whereas the latter twoarestereospe-
cifically methylated at the alpha carbon, again, likely involving
SAM as the methyl source. Cysteine-derived linear arrangements
of 2,4-disubstituted thiazolines/thiazole rings possess a diverseChemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 899
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Carbon dC
a dH, multiplicity (Hz)
b COSY HMBC (1H to 13C) NOESY
1 161.6
2 145.6
3 127.8 8.09, s 1, 2, 4
4 169.2
5 37.7 a3.12, dd (14.4, 1.8) 6, 5b 4, 6, 7 17
b3.22, dd (14.4, 10.2) 6, 5a 4, 6, 7 17
6 77.5 3.70, d (9.6) 5a, 5b, 7 4, 5, 8, 10, 17 8, 10
7 39.2 1.95, m 6, 8, 17 8, 9, 17
8 76.7 3.43, dd (10.2, 4.8) 7, 9 9, 16, 17 6, 10, 16
9 33.9 1.68, m 8, 10, 16 8, 10 15, 17
10 83.2 2.88 dd (10.2, 1.8) 9, 11 6, 8, 11, 12, 15, 16 6, 8, 16
11 33.2 1.66, m 10, 15, 12a, 12b 12, 13, 15 14
12 37.1 a1.24, m 11, 12b 10, 11, 13, 14, 15 15
b1.33, m 11, 12a 10, 11, 13, 14, 15 15
13 20.4 1.16, m 14 11, 12, 14
14 14.4 0.79, t (7.2) 13 12, 13 11
15 13.1 0.87, d (7.2) 11 10, 11, 12 9, 12a, 12b
16 13.0 0.88, d (6.0) 9 8, 9, 10 8, 10
17 5.6 0.96, d (6.6) 7 6, 7, 8 5a, 5b, 9
18 52.5 3.95, s 1, 2
a Recorded at 125 MHz.
b Recorded at 500 MHz.rangeofbiological activities (Carmeli et al., 1990,1991,1993;Nae-
geli andZahner, 1980; Jansenet al., 1992) andarebelieved toplay
an important role in their mechanism of action (Wipf et al., 1998;
Kwan et al., 2008). The fourth residue, isoleucine, is modified by
a PKS extension, reduction of the ketone to an alcohol, andmeth-
ylation of the acetate C-2 carbon. As a result of these tailoring
reactions, this homologated Ile residue is chirally dense with four
contiguous asymmetric centers. Next, a hydroxy acid common
to many cyanobacterial natural products, hydroxyisovaleric acid
(Hiva), is incorporated into hoiamide A (1). In the one other case
where the gene structure for Hiva incorporation has been studied
in a cyanobacterium—the natural product hectochlorin (Ramasw-
amy et al., 2007)—this occurs through initial activation of the
a-keto acid and subsequent reduction to the hydroxy-acid once
tethered to the NRPS condensation domain. Finally, the only
amino acid in hoiamide A (1) not modified by a secondary tailoring
reaction, L-threonine, is attached as the final residue. This termi-
nating amino acid sequence, Thr-Hiva, has not been described
in any other known cyanobacterial natural product. Finally, the
C34 hydroxyl group in the Dmetua group is presumably involved
in both hydrolysis from the NRPS as well as ester formation to
the final 26-membered cyclic depsipeptide structure.
Hoiamide A: Pharmacological Studies
Hoiamide A Produces Sodium Influx in Neocortical
Neurons
Systematic screening of natural product extracts, using a combi-
nation of high throughput Ca2+ and Na+ influx assays in neocor-
tical neurons, led to the identification of the novel bioactive
cyclic peptide hoiamide A (1). Further characterization demon-900 Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevstrated that hoiamide A produced a rapid and concentration-
dependent elevation of neuronal [Na+]i in neocortical neurons
as detected with the sodium-sensitive fluorescent dye, SBFI
(Figure 4A). The concentration-response curve for hoiamide
A-induced sodium influx was best fit by a three-parameter
logistic equation yielding an EC50 value of 2.31 mM (95% confi-
dence intervals [95% CI], 0.82–6.53) (Figure 4C). We and others
have demonstrated that batrachotoxin is a full agonist at neuro-
toxin site 2 on the sodium channel a subunit (Cao et al., 2008;
Catterall, 1977). We therefore compared the relative efficacies
of hoiamide A and batrachotoxin as stimulators of neuronal
[Na+]i. As shown in Figure 4B, batrachotoxin produced a rapid
and concentration-dependent elevation of neuronal [Na+]i with
an EC50 value of 11.4 nM (95% CI, 6.92–18.8). The EC50 value
for batrachotoxin-induced sodium influx is consistent with that
reported by Cao et al. (2008). The maximum response for batra-
chotoxin-inducedelevationof neuronal [Na+]i wasgreater than60
mM, whereas the maximal response for hoiamide A–induced
increase in [Na+]i was less than 20 mM. Nonlinear regression
analysis of the hoiamideA concentration-response data revealed
that the relative efficacy of hoiamide A for elevation of neuronal
[Na+]i was 0.38 (Figure 4C). These data are consistent with hoia-
mide A (1) acting as a partial agonist at neurotoxin site 2.
TTX Antagonizes Hoiamide A–Induced Elevation
of Neuronal [Na+]i in Neocortical Neurons
VGSCs and the N-methyl-D-aspartic acid (NMDA) and a-amino-
3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) subtypes
of glutamate receptors represent the main routes for sodium
influx in neocortical neurons. To further explore the mechanism
of hoiamide A–induced sodium influx, we evaluated the effectsier Ltd All rights reserved
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Structure and Pharmacology of Hoiamide AFigure 4. Hoiamide A Stimulates Na+ Influx in Neocortical Neurons
(A) Time-response relationships for hoiamide A–induced elevation of neuronal [Na+]i in neocortical neurons.
(B) Time-response relationships for batrachotoxin-induced elevation of neuronal [Na+]i in neocortical neurons.
(C) Nonlinear regression analysis of the peak SBFI (340/380) response versus hoiamide A and batrachotoxin concentration.
(D) TTX inhibition of hoiamide A–induced elevation of neuronal [Na+]i. These data were obtained from at least three different cultures performed in duplicate.of TTX (VGSC inhibitor), MK-801 (NMDA receptor antagonist),
and NBQX (AMPA receptor antagonist) on hoiamide A–induced
elevation of neuronal [Na+]i. Pretreatment with TTX (1 mM) elimi-
nated the hoiamide A–induced elevation of neuronal [Na+]i
demonstrating the requirement for activation of VGSCs for hoia-
mide A (1)–induced sodium influx (Figure 4D). Pretreatment with
MK-801 (1 mM) produced a partial, but statistically significant,
decrease in hoiamide A–induced elevation of neuronal [Na+]i
(Figure S24A). This effect may be due to the engagement of
NMDA receptors as a result of membrane depolarization,
a consequence of activation of VGSCs. The AMPA receptor
antagonist NBQX (5 mM) had no effect on hoiamide A–induced
Na+ influx (Figure S24B). Considered together, these data
demonstrate that hoiamide A (1) is a VGSC activator.
Deltamethrin and PbTx-3 Enhancement of Hoiamide
A–Induced Elevation of Neuronal [Na+]i in Neocortical
Neurons
Although the multiple neurotoxin sites on VGSCs are topolog-
ically distinct, there are strong allosteric interactions among
them. Pyrethroids are synthetic insecticidal compounds that
resemble natural pyrethrins (Lombet et al., 1988). PyrethroidsChemistry & Biology 16, 8specifically bind to a site on the sodium channel a subunit
that is distinct from neurotoxin site 1–6 and is allosterically
coupled to sites 2, 3, and 5 (Trainer et al., 1993; Trainer
et al., 1997). Therefore, to further explore the molecular mech-
anism of action for hoiamide A (1), we assessed the effect of
a subthreshold concentration of deltamethrin (0.1 mM) on the
hoiamide A–induced elevation of neuronal [Na+]i in neocortical
neurons. A concentration of deltamethrin (0.1 mM), which was
inactive alone (Figure S25B), significantly increased the
maximum response of hoiamide A–induced sodium influx
from an AUC (fluorescence 3 min) value of 89.9 (95% CI,
81.5–98.2) to 141.4 (95% CI, 119.7–162.5) without altering
the hoiamide A EC50 value (Figures 5A, 5C, and 5E). These
data provide direct evidence that hoiamide A (1) binds to
a site on the sodium channel that is allosterically coupled to
the pyrethroid insecticide binding site. Brevetoxins are potent
lipid-soluble polyether neurotoxins produced by the marine
dinoflagellate, Karenia brevis (Baden, 1989). Brevetoxins
interact specifically with neurotoxin site 5 on the a subunit
of VGSC. Evidence for the allosteric coupling of neurotoxin
site 2 and site 5 has been provided by demonstrating that93–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 901
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Structure and Pharmacology of Hoiamide AFigure 5. Deltamethrin (0.1 mM) and PbTx-3 (5 nM) Enhance Hoiamide A–Induced Elevation of Neuronal [Na+]i
(A) Time-response relationships for hoiamide A–induced elevation of neuronal [Na+]i.
(B) Time-response relationships for hoiamide A–induced elevation of neuronal [Na+]i in the presence of 5 nM PbTx-3.
(C) Time-response relationships for hoiamide A–induced elevation of neuronal [Na+]i in the presence of 0.1 mM deltamethrin.
(D) Nonlinear regression analysis of the SBFI response (area under the curve [AUC]) versus the concentration of hoiamide A in the presence and absence of 5 nM
PbTx-3.
(E) Nonlinear regression analysis of the SBFI response (AUC) versus the concentration of hoiamide A in the presence and absence of 0.1 mM deltamethrin. Each
data point represents the mean ± SEM from two experiments performed in triplicate.the binding of [3H]batrachotoxin to neurotoxin site 2 is
enhanced by brevetoxins (Li et al., 2001; Sharkey et al.,
1987). We therefore determined whether an allosteric interac-
tion existed between site 5 and the hoiamide A (1) binding site.
A concentration of brevetoxin 3 (PbTx-3, 5 nM), which was
inactive alone (Figure S25A), also produced a significant
increase in the maximum response of hoiamide A–induced
sodium influx from an AUC (fluorescence 3 min) value of
89.9 (95% CI, 81.5–98.2) to 143.4 (95% CI, 129.7–157.4)
with no corresponding effect on the hoiamide A EC50 value
(Figures 5A, 5B, and 5D). These data suggest that a positive902 Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevallosteric interaction exists between the hoiamide A (1) binding
site and neurotoxin site 5 on VGSCs. These positive allosteric
interactions between hoiamide A, and PbTx-3 and
deltamethrin are therefore consistent with hoiamide A interact-
ing with neurotoxin site 2.
Hoiamide A Inhibits the Specific Binding of
[3H]batrachotoxin A 20-a-benzoate ([3H]BTX) to
Neurotoxin Site 2 on VGSCs in Neocortical Neurons
[3H]BTX is a radioligand probe that binds to neurotoxin site 2 on
the VGSC a subunit (Catterall et al., 1981). This ligand interacts
preferentially to the active or open conformation of the channel,ier Ltd All rights reserved
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induced by the binding of neurotoxins at other sites on the
sodium channel a subunit. We therefore used [3H]BTX as a probe
to provide further evidence for hoiamide A (1) interaction with
neurotoxin site 2 on VGSCs. Inasmuch as the specific binding
of [3H]BTX is quite low in the absence of other sodium channel
gating modifiers and is dramatically increased by the allosteric
interaction of deltamethrin and brevetoxin, we assessed the
influence of hoiamide A on [3H]BTX binding in the presence of
these allosteric modulators. As depicted in Figure 6, hoiamide
A (1) produced a concentration-dependent inhibition of [3H]BTX-
specific binding in the presence of PbTx-3 (300 nM) and delta-
methrin (10 mM). The hoiamide A IC50 value was 92.8 nM (95%
CI, 56.6–152.1). The prototypic neurotoxin site 2 ligand veratri-
dine also inhibited [3H]BTX-specific binding to VGSCs with an
Figure 6. Hoiamide A and Veratridine Inhibit
the Specific Binding of [3H]BTX to VGSCs
Each data point represents the mean ± SEM from
three experiments performed in triplicate.
Figure 7. Hoamide A Titration in the Presence of a Saturating Concentration of the Full Agonist Batrachotoxin
(A) Time-response relationships for hoiamide A reversal of batrachotoxin (30 nM)–induced elevation of neuronal [Na+]i.
(B) Nonlinear regression analysis of the hoiamide A-induced reversal of the integrated SBFI response (AUC) to batrachotoxin (30 nM) in neocortical neurons. Histo-
gram represents the responses to batrachotoxin (30 nM) and hoiamide A (30 mM) alone. These experiments were performed twice in triplicate with similar results.
IC50 value of 33.0 mM (95% CI, 24.2–
45.1), indicating that it was much less
potent thanhoiamideA (Figure 6).Consid-
ered together, these data directly demon-
strate that hoiamide A (1) interacts with
neurotoxin site 2 on the VGSC a subunit.
Inhibition of BTX-Induced Increase
in Neuronal [Na+]i by Hoiamide A
We have previously demonstrated that
saturating concentrations of neurotoxin
site 2 ligands produce different maximal
responses in sodium influx (Cao et al.,
2008). We have demonstrated herein
that hoiamide A (1) produced a maximum
sodium influx that was less than that of
the full agonist, batrachotoxin (Figure 4C). This suggests that
hoiamide A acts as a partial agonist at neurotoxin site 2 on
VGSCs. Catterall (1977) first demonstrated partial agonism at
neurotoxin site 2 with a combination of a full activator (batracho-
toxin) and a weak activator (aconitine). This interaction resulted
in an inhibition of the response to the full activator by the weak
activator. We have previously demonstrated that gambierol,
a low-efficacy partial agonist at neurotoxin site 5, inhibited the
full agonist PbTx-1-induced elevation of neuronal [Na+]i (Cao
et al., 2008). Thus, a low-efficacy agonist may act as a functional
antagonist of a high-efficacy agonist at either neurotoxin site 2 or
5 on VGSCs (Cao et al., 2008). Given themodest efficacy of hoia-
mide A (1) as a stimulator of neuronal [Na+]i, we performed a titra-
tion with hoiamide A in the presence of a fixed concentration of
the full agonist, batrachotoxin (30 nM). As depicted in Figure 7,Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsevier Ltd All rights reserved 903
Chemistry & Biology
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dent reduction in batrachotoxin-induced sodium influx (SBFI
AUC). These data demonstrate that hoiamide A (1) and batracho-
toxin interact in a mutually exclusive manner with a common
recognition site on VGSCs. The partial agonist activity of hoia-
mide A is therefore demonstrated by the ability of hoiamide A
to produce a concentration-dependent inhibition of batracho-
toxin-induced elevation of [Na+]i in neocortical neurons.
SIGNIFICANCE
Marine cyanobacteria represent a particularly rich source of
structurally diverse neurotoxic secondary metabolites, such
as antillatoxin, kalkitoxin, and jamaicamide A (Grindberg
et al., 2008). In the present study, we describe the isolation
and structure elucidation of hoiamide A (1), a cyclic depsi-
peptide discovered in an environmental assemblage of
Lyngbyamajuscula and Phormidium gracile. Featuring three
heavily modified regions (peptidic, triheterocyclic, and poly-
ketide), hoiamide A (1) illustrates the intricate biosynthetic
machinery responsible for the production of cyanobacterial
compounds. Using a combination of neurochemical and
pharmacological approaches, we have demonstrated that
hoiamide A (1) represents a new chemotype to exhibit partial
agonism at the neurotoxin site 2 on VGSCs. VGSCs are vital
for central nervous system function. We and others have
shown that an array of sodium channel gating modifiers
produce [Na+]i increments that are of sufficient magnitude
to increase NMDA receptor channel activity (Cao et al.,
2008; Yu and Salter, 1998; Yu and Salter, 1999). Sodium
channel activators therefore appear capable of mimicking
activity-dependent control of neuronal development by up-
regulating NMDA receptor signaling pathways that influence
neuronal growth and plasticity (George et al., 2009). VGSC
activators may accordingly represent a novel pharmaco-
logic strategy to regulate neuronal plasticity. Hoiamide A (1)
therefore represents a structurally novel lead compound for
drugs capable of promoting neuronal growth and plasticity.
EXPERIMENTAL PROCEDURES
See Supplemental Data for General Experimental Procedures and Analytical
Data for Derivatives of Hoiamide A (1).
Collection of Biological Material
A composite collection of the marine cyanobacteria Lyngbya majuscula and
Phormidium gracile (voucher specimen available from WHG as collection
number PNG5-28-02-12) was obtained at a depth of 5–10 m from Hoia Bay,
Papua New Guinea, in May 2002 (10 15.990 S, 150 46.169 E). Samples
were stored in 70% EtOH at 20C prior to extraction. Taxonomy was
assigned by microscopic comparison with the description given by Komarek
and Anagnostidis (2005), as well as Geitler (1932) (Supplemental Data).
Extraction and Isolation
Approximately 186 g (dry wt) of the cyanobacteria was extracted repeatedly
with CH2Cl2/MeOH (2:1) to yield 4.377 g of crude extract. A portion of this
material (3.5474 g) was fractionated by silica gel vacuum liquid chromatog-
raphy using a stepwise gradient solvent system of increasing polarity starting
from 10% EtOAc in hexanes to 100% MeOH, to produce nine fractions (A–I).
The bioactive fraction F (0.7890 g) was subjected to a 1HNMR-guided fraction-
ation composed of two silica gel columns (60% and 50% EtOAc in hexanes,
respectively) and reversed-phase HPLC (Phenomenex Jupiter 10 m C18,904 Chemistry & Biology 16, 893–906, August 28, 2009 ª2009 Elsev250 3 10 mm, 65% MeCN/H2O with 0.1% TFA at 3 mL/min, detection at
210, 254 and 280 nm), to yield 150.0 mg of compound (1).
Hoiamide A (1): colorless amorphous solid; [a]23D +5 (c 5.5, CHCl3); UV
(MeCN) lmax 250 nm (log 3 3.99); IR (neat) 3379, 2967, 2932, 2879, 1743,
1607, 1519, 1154, 1085, 735 cm1; for 1H and 13C NMR data, see Table 1;
HR ESIMS m/z [M+H]+ 926.4446 (calcd for C44H71N5O10S3, 926.4441).
Neocortical Neuron Culture
Primary cultures of neocortical neurons were obtained from embryonic day 16
Swiss-Webster mice as described elsewhere (Cao et al., 2007). Briefly, preg-
nant mice were euthanized by CO2 asphyxiation, and embryos were removed
under sterile conditions. Neocortices were collected, stripped of meninges,
minced by trituration with a Pasteur pipette, and treated with trypsin for
25 min at 37C. The cells were then dissociated by two successive trituration
and sedimentation steps in soybean trypsin inhibitor and DNase containing
isolation buffer, centrifuged, and resuspended in Eagle’s minimal essential
medium with Earle’s salt (MEM) and supplemented with 1 mM L-glutamine,
10% fetal bovine serum, 10% horse serum, 100 IU/ml penicillin, and
0.10mg/ml streptomycin (pH 7.4). Cells were plated onto poly-L-lysine-coated
96-well (9 mm), clear-bottomed, black-well culture plates (Costar) at a density
of 1.5 3 105 cells/well. Cells were then incubated at 37C in a 5% CO2 and
95% humidity atmosphere. Cytosine arabinoside (10 mM) was added to the
culture medium on day 2 after plating to prevent proliferation of nonneuronal
cells. The culture media was changed both on days 5 and 7 using a serum-
free growth medium containing Neurobasal Medium supplemented with
B-27, 100 IU/mL penicillin, 0.10 mg/mL streptomycin, and 0.2 mM L-gluta-
mine. Neocortical cultures were used in experiments between 8–13 days
in vitro (DIV). All animal use protocols were approved by the Institutional Animal
Care and Use Committee (IACUC).
Intracellular Sodium Concentration ([Na+]i) Measurement
The neocortical neurons cultured in 96-well plates (DIV 8-13) were washed four
times with Locke’s buffer (8.6 mMHEPES, 5.6 mMKCl, 154 mMNaCl, 5.6 mM
glucose, 1.0 mMMgCl2, 2.3 mMCaCl2, and 0.0001 mM glycine [pH 7.4]) using
an automated cell washer (BioTeck Instrument Inc., VT, USA). The background
fluorescence of each well was measured and averaged prior to dye loading.
Cells were then incubated for 1 hr at 37C with dye loading buffer (50 mL/
well) containing 10 mM SBFI-AM and 0.02% Pluronic F-127. After 1 hr incuba-
tion in dye loading medium, cells were washed five times with Locke’s buffer,
leaving a final volume of 150 ml in each well. The plate was then transferred to
the plate chamber of a FLEXstationTM II (Molecular Devices, Sunnyvale, CA,
USA). Cells were excited at 340 nm and 380 nm and Na+-bound SBFI emission
was detected at 505 nm. Fluorescence readings were taken once every 5 s for
60 s to establish the baseline, and then 50 ml of neurotoxin containing solution
(43) was added to each well from the compound plate at the rate of 52 mL/s,
yielding a final volume of 200 mL/well.
Whole Cell Binding Assay
At 8–10 days in culture, neocortical neurons cultured in 12-well plates were
used for measurement of [3H]BTX binding. Cells were first rinsed three times
each with 1 ml of buffer A containing 140 mM choline chloride, 5 mM KCl,
1.8 mMCaCl2, 0.8 mMMgSO4, and 10mMHEPES (pH 7.4 with 1M Tris). Cells
were then incubated with 0.5 ml of buffer B (buffer A plus 2 mg/mL BSA) con-
taining 2nM [3H]BTX, 300nMPbTx-3, 10mMdeltamethrin, andvarious concen-
trations of hoiamide A for 3–4 h. After incubation, cells were rinsed three times
with 1ml of buffer Abefore lysiswith 500ml of 1%TritonX-100under a condition
of constant shaking overnight. A 400 ml aliquot of the resulting lysate was
collected, and [3H]BTX bound was measured by liquid scintillation counter.
Nonspecific binding of [3H]BTX was determined as [3H]BTX bound in the pres-
ence of 200 mM veratridine. Our preliminary results indicated that whole cell
assays conducted at room temperature (22C) provided an optimum signal-
to-noise ratio; all binding experiments were conducted at 22C.
Data Analysis
The raw emission data at each excitation wavelength were exported to an
Excel work sheet and corrected for background fluorescence. The SBFI fluo-
rescence ratios (340/380) versus time were then analyzed, and time-response
and concentration-response graphs generated using Graphpad Prismier Ltd All rights reserved
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Structure and Pharmacology of Hoiamide Asoftware (Graphpad Software Inc., San Diego, CA). The EC50 and maximum
response values were determined by nonlinear regression analysis using a
logistic equation.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
twenty-five figures and can be found with this article online at http://www.
cell.com/chemistry-biology/supplemental/S1074-5521(09)00212-9.
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